Skip to Main Content

Paper Details

Pharmacovigilance pregnancy data in a large population of patients with chronic inflammatory disease exposed to certolizumab pegol.
Therapeutic Advances in Musculoskeletal Disease
4
2022
CID, CIDs, CZP, Chronic inflammatory diseases, Congenital Defects, Congenital malformations, Fc, TNFi, Tumor necrosis factor, certolizumab pegol, chronic, chronic inflammatory disease, congenital malformations, inflammatory conditions, patients, rheumatic diseases, stillbirths, women
Author NameAffiliation
Marla C DubinskyIcahn School of Medicine at Mount Sinai Hospital
  • 1 - 1

Datasets

Release 1.2